S9 Ep22: Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC

from OncLive® On Air · host OncLive® On Air

Dr Kelley discusses standard first-line treatment options for patients with advanced HCC, key findings from the phase 3 HIMALAYA trial, and the safety profile of the STRIDE regimen in this population.

Episode metadata supplied by the publisher feed · Published Aug 31, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

S9 Ep22: Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC

0:00 14:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 14 minutes long.

When was this OncLive® On Air episode published?

This episode was published on August 31, 2023.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!